322 related articles for article (PubMed ID: 33648823)
21. Investigating the utilization of beam-specific apertures for the intensity-modulated proton therapy (IMPT) head and neck cancer plans.
Rana S; Storey M; Manthala Padannayil N; Shamurailatpam DS; Bennouna J; George J; Chang J
Med Dosim; 2021 Summer; 46(2):e7-e11. PubMed ID: 33246881
[TBL] [Abstract][Full Text] [Related]
22. Comparison of intensity-modulated radiation therapy (IMRT), 3D conformal proton therapy and intensity-modulated proton therapy (IMPT) for the treatment of metastatic brain cancer.
Sullivan M; Jin H; Ahmad S
Med Dosim; 2023 Summer; 48(2):73-76. PubMed ID: 36690513
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
[TBL] [Abstract][Full Text] [Related]
24. Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons.
Müller BS; Duma MN; Kampfer S; Nill S; Oelfke U; Geinitz H; Wilkens JJ
Phys Med; 2015 May; 31(3):266-72. PubMed ID: 25724350
[TBL] [Abstract][Full Text] [Related]
25. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
26. Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.
Murthy V; Master Z; Gupta T; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Agarwal J
J Cancer Res Ther; 2010; 6(2):194-8. PubMed ID: 20622367
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
28. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
30. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric impact of systematic spot position errors in spot scanning proton therapy of head and neck tumor.
Yasui K; Omi Y; Shimomura A; Muramatsu R; Iwata H; Ogino H; Hayashi N
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147973
[TBL] [Abstract][Full Text] [Related]
32. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
33. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric verification of surface and superficial doses for head and neck IMRT with different PTV shrinkage margins.
Shiau AC; Lai PL; Liang JA; Shueng PW; Chen WL; Kuan WP
Med Phys; 2011 Mar; 38(3):1435-43. PubMed ID: 21520855
[TBL] [Abstract][Full Text] [Related]
35. Study of volumetric and dosimetric changes during fractionated radiotherapy in head and neck cancers: A single centre experience.
Kumar V; Nautiyal V; Kant R; Gupta M; Bansal S; Ahmad M
J Cancer Res Ther; 2021; 17(1):235-241. PubMed ID: 33723161
[TBL] [Abstract][Full Text] [Related]
36. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
[TBL] [Abstract][Full Text] [Related]
37. Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges.
Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gerard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Benezery K; Herault J; Poortmans P; Bourhis J; Thariat J;
Radiother Oncol; 2020 Jun; 147():30-39. PubMed ID: 32224315
[TBL] [Abstract][Full Text] [Related]
38. Dose comparison of robustly optimized intensity modulated proton therapy (IMPT) vs IMRT and VMAT photon plans for testicular seminoma.
Rønde HS; Kronborg C; Høyer M; Hansen J; Bak ME; Agergaard SN; Als AB; Agerbæk M; Lauritsen J; Meidahl Petersen P; Dysager L; Kallehauge JF
Acta Oncol; 2023 Oct; 62(10):1222-1229. PubMed ID: 37683054
[TBL] [Abstract][Full Text] [Related]
39. Modeling the dosimetry of organ-at-risk in head and neck IMRT planning: an intertechnique and interinstitutional study.
Lian J; Yuan L; Ge Y; Chera BS; Yoo DP; Chang S; Yin F; Wu QJ
Med Phys; 2013 Dec; 40(12):121704. PubMed ID: 24320490
[TBL] [Abstract][Full Text] [Related]
40. Intensity Modulated Proton Therapy Better Spares Non-Adjacent Organs and Reduces the Risk of Secondary Malignant Neoplasms in the Treatment of Sinonasal Cancers.
Lewis L; Kreinbrink P; Richardson M; Westerfield M; Doberstein M; Zhang Y; Redmond K; Takiar V
Med Dosim; 2022 Summer; 47(2):117-122. PubMed ID: 34952761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
